ARCHIVES

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

ACS Stirs Discord By Placing Its Own Logo On A Coalition’s Petition, Then Reconsiders

February 7, 1997

Growing Number Of New Research Ideas Create NCI Dilemma; How to Fund Them With A Flat Budget

October 1, 1982

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

DRCCA Completes New Cancer control Research Guidelines

August 5, 1983

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992